Enhancement of osteoblast differentiation that is inhibited by titanium particles through inactivation of NFATc1 by VIVIT peptide

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 3 A, 2010, Pages 727-734

  Maoqiang, Li ^a   Zhenan, Zhu ^a   Fengxiang, Liu ^a   Gang, Wang ^a   Yuanqing, Mao ^a   Ming, Liu ^a   Xin, Zhao ^a   Tingting, Tang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

NFATc1; Osteoblast; Osteolysis; Titanium particles

Indexed keywords

BONE FORMATION; INHIBITION PROCESS; NFATC1; NUCLEAR FACTOR OF ACTIVATED T-CELLS; OSTEOBLAST DIFFERENTIATION; OSTEOBLASTIC DIFFERENTIATION; OSTEOLYSIS; OSTEOPROGENITORS; PERIPROSTHETIC OSTEOLYSIS; RAT CALVARIA; THERAPEUTIC TARGETS; TI PARTICLES; TITANIUM PARTICLES; TOXIC EFFECT; WEAR DEBRIS; WEAR PARTICLES;

BONE; CELL CULTURE; DEBRIS; MINERALOGY; PEPTIDES; TITANIUM;

OSTEOBLASTS;

ARGINYLARGINYLARGINYLARGINYLARGINYLGLYCYLGLYCYLGLYCYLMETHIONYLALANYLGLYCYLPROLYLHISTIDYLPROLYLVALYLISOLEUCYLVALYLISOLEUCYLTHREONYLGLYCYLPROLYLHISTIDYLGLUTAMYL GLUTAMIC ACID; PEPTIDE DERIVATIVE; TITANIUM; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALVARIA; CELL DIFFERENTIATION; CELL VIABILITY; FETUS; GENE EXPRESSION; MALE; MINERALIZATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; RAT;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELLS, CULTURED; MALE; NFATC TRANSCRIPTION FACTORS; OLIGOPEPTIDES; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; SKULL; TITANIUM;

EID: 78249260881     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32891     Document Type: Article

References (46)

1. Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP,. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res 2007; 454: 251 -261.
2. Holt G, Murnaghan C, Reilly J, Meek RM,. The biology of aseptic osteolysis. Clin Orthop Relat Res 2007; 460: 240 -252.
3. Skoglund B, Aspenberg P,. PMMA particles and pressure-A study of the osteolytic properties of two agents proposed to cause prosthetic loosening. J Orthop Res 2003; 21: 196 -201.
4. Clohisy JC, Teitelbaum S, Chen S, Erdmann JM, Abu-Amer Y,. Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-κB activation in osteoclast precursor cells. J Orthop Res 2002; 20: 174 -181.
5. Pioletti DP, Kottelat A,. The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts. Biomaterials 2004; 25: 5803 -5808.
6. Rakshit DS, Ly K, Sengupta TK, Nestor BJ, Sculco TP, Ivashkiv LB, Purdue PE,. Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-gamma. Mechanistic insights and implications for periprosthetic osteolysis. J Bone Joint Surg Am 2006; 88: 788 -799.
7. Horowitz SM, Gautsch TL, Frondoza CG, Riley L Jr,. Macrophage exposure to polymethyl methacrylate leads to mediator release and injury. J Orthop Res 1991; 9: 406 -413.
8. Horowitz SM, Gonzales JB,. Inflammatory response to implant particulates in a macrophage/osteoblast coculture model. Calcif Tissue Int 1996; 59: 392 -396.
9. Goodman SB, Davidson JA, Song Y, Martial N, Fornasier VL,. Histomorphological reaction of bone to different concentrations of phagocytosable particles of high-density polyethylene and Ti-6Al-4V alloy in vivo. Biomaterials 1996; 17: 1943 -1947.
10. Chiu R, Ma T, Smith RL, Goodman SB,. Polymethylmethacrylate particles inhibit osteoblastic differentiation of bone marrow osteoprogenitor cells. J Biomed Mater Res A 2006; 77: 850 -856.
11. Okafor CC, Haleem-Smith H, Laqueriere P, Manner PA, Tuan RS,. Particulate endocytosis mediates biological responses of human mesenchymal stem cells to titanium wear debris. J Orthop Res 2006; 24: 461 -473.
12. Vermes C, Chandrasekaran R, Jacobs JJ, Galante JO, Roebuck KA, Glant TT,. The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg Am A 2001; 83: 201 -211.
13. Dean DD, Schwartz Z, Blanchard CR, Liu Y, Agrawal CM, Lohmann CH, Sylvia VL, Boyan BD,. Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells. J Orthop Res 1999; 17: 9 -17.
14. Lohmann CH, Schwartz Z, Koster G, Jahn U, Buchhorn GH, MacDougall MJ, Casasola D, Liu Y, Sylvia VL, Dean DD, Boyan BD. Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition. Biomaterials 2000; 21: 551 -561.
15. Wang ML, Nesti LJ, Tuli R, Lazatin J, Danielson KG, Sharkey PF, Tuan RS,. Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 2002; 20: 1175 -1184.
16. Hogan PG, Chen L, Nardone J, Rao A,. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003; 17: 2205 -2232.
17. Zayzafoon M,. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem 2006; 97: 56 -70.
18. Liu F, Zhu Z, Mao Y, Liu M, Tang T, Qiu S,. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide. Biomaterials 2009; 30: 1756 -1762.
19. Yeo H, Beck LH, McDonald JM, Zayzafoon M,. Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation. Bone 2007; 40: 1502 -1516.
20. Yeo H, McDonald JM, Zayzafoon M,. NFATc1: A novel anabolic therapeutic target for osteoporosis. Ann NY Acad Sci 2006; 1068: 564 -567.
21. Zayzafoon M,. Inhibition of NFAT increases osteoblast differentiation by increasing Fra-2 expression. J Musculoskelet Neuronal Interact 2005; 5: 347.
22. von Knoch M, Jewison DE, Sibonga JD, Sprecher C, Morrey BF, Loer F, Berry DJ, Scully SP,. The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo. J Orthop Res 2004; 22: 237 -243.
23. Lee SS, Woo CH, Chang JD, Kim JH,. Roles of Rac and cytosolic phospholipase A2 in the intracellular signalling in response to titanium particles. Cell Signal 2003; 15: 339 -345.
24. Bellows CG, Aubin JE, Heersche JN, Antosz ME,. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986; 38: 143 -154.
25. Bancroft GN, Sikavitsas VI, van den Dolder J, Sheffield TL, Ambrose CG, Jansen JA, Mikos AG,. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci USA 2002; 99: 12600 -12605.
26. Adams CJ, Storrie B,. A simple DNA-dependent fluorescence enhancement assay for cell number. J Histochem Cytochem 1981; 29: 326 -328.
27. Kim HK, Kim JH, Abbas AA, Kim DO, Park SJ, Chung JY, Song EK, Yoon TR,. Red light of 647 nm enhances osteogenic differentiation in mesenchymal stem cells. Lasers Med Sci 2009; 24: 214 -222.
28. Itoh D, Yoneda S, Kuroda S, Kondo H, Umezawa A, Ohya K, Ohyama T, Kasugai S,. Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (EEEEEEEPRGDT) in vitro. J Biomed Mater Res A 2002; 62: 292 -298.
29. Stadelmann VA, Terrier A, Pioletti DP,. Microstimulation at the bone-implant interface upregulates osteoclast activation pathways. Bone 2008; 42: 358 -364.
30. Choudhary S, Alander C, Zhan P, Gao Q, Pilbeam C, Raisz L,. Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist. Prostaglandins Other Lipid Mediat 2008; 86: 35 -40.
31. Sunters A, Madureira PA, Pomeranz KM, Aubert M, Brosens JJ, Cook SJ, Burgering BM, Coombes RC, Lam EW,. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Res 2006; 66: 212 -220.
32. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS,. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. Endocrinology 1996; 137: 4398 -4408.
33. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A,. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999; 285: 2129 -2133.
34. Yu H, van Berkel TJ, Biessen EA,. Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders. Cardiovasc Drug Rev 2007; 25: 175 -187.
35. MacQuarrie RA, Fang Chen Y, Coles C, Anderson GI,. Wear-particle-induced osteoclast osteolysis: The role of particulates and mechanical strain. J Biomed Mater Res B Appl Biomater 2004; 69: 104 -112.
36. Tamaki Y, Sasaki K, Sasaki A, Takakubo Y, Hasegawa H, Ogino T, Konttinen YT, Salo J, Takagi M,. Enhanced osteolytic potential of monocytes/macrophages derived from bone marrow after particle stimulation. J Biomed Mater Res B Appl Biomater 2008; 84: 191 -204.
37. Bellows CG, Aubin JE,. Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. Dev Biol 1989; 133: 8 -13.
38. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS,. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990; 143: 420 -430.
39. Yamamoto N, Furuya K, Hanada K,. Progressive development of the osteoblast phenotype during differentiation of osteoprogenitor cells derived from fetal rat calvaria: model for in vitro bone formation. Biol Pharm Bull 2002; 25: 509 -515.
40. Chiu R, Ma T, Smith RL, Goodman SB,. Polymethylmethacrylate particles inhibit osteoblastic differentiation of MC3T3-E1 osteoprogenitor cells. J Orthop Res 2008; 26: 932 -936.
41. Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T, Rao A,. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 1993; 365: 352 -355.
42. Selvamurugan N, Kwok S, Partridge NC,. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-β1-stimulated collagenase-3 expression in human breast cancer cells. J Biol Chem 2004; 279: 27764 -27773.
43. Macian F, Lopez-Rodriguez C, Rao A,. Partners in transcription: NFAT and AP-1. Oncogene 2001; 20: 2476 -2489.
44. Rao A, Luo C, Hogan PG,. Transcription factors of the NFAT family: Regulation and function. Annu Rev Immunol 1997; 15: 707 -747.
45. Yoshida T, Suzuki T, Sato H, Nishina H, Iba H,. Analysis of fra-2 gene expression. Nucleic Acids Res 1993; 21: 2715 -2721.
46. Noguchi H, Matsushita M, Okitsu T, Moriwaki A, Tomizawa K, Kang S, Li ST, Kobayashi N, Matsumoto S, Tanaka K, Matsui H. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 2004; 10: 305 -309.